Clinical trial
Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN): a Retrospective Study of Patients Diagnosed in France From 2000 to 2013
NCT02859623 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN): a Retrospective Study of Patients Diagnosed in France From 2000 to 2013
- Lead sponsor
- Centre Hospitalier Universitaire de Besancon
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- Not reported
- Enrollment
- 86 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
blastic plasmacytoid dendritic cell neoplasm, hematological malignancies